Jonathan Wild (venture capitalist)

Jonathan Wild (venture capitalist)
Name	Jonathan Wild
Birth date	1970s
Occupation	Venture capitalist, investor, board member
Years active	1990s–present
Known for	Early-stage technology investing, fintech, healthtech

Jonathan Wild (venture capitalist) Jonathan Wild is a private equity and venture capital investor active in early-stage technology and growth-stage financing. He has been associated with multiple venture firms, corporate ventures, and advisory boards across Silicon Valley, London, and New York City. Wild's portfolio spans fintech, healthcare technology, software as a service, and deep-tech startups, with a public presence in media and philanthropy.

Early life and education

Wild was born in the 1970s and raised in Manchester. He earned a Bachelor of Science from University of Cambridge and later completed an MBA at Harvard Business School, where he studied alongside classmates from McKinsey & Company and Goldman Sachs recruiting pipelines. During his studies he interned at Silicon Valley Bank and participated in Y Combinator-adjacent networks and industry conferences such as TechCrunch Disrupt and Web Summit.

Career

Wild began his career in investment banking at Morgan Stanley before moving into technology venture capital at a boutique firm tied to Accel Partners-era investors. He co-founded a venture practice that partnered with corporate innovation arms of BP, Samsung, and GE to structure minority stakes and strategic alliances. Wild later joined a global venture firm where he led North American technology investments and worked with limited partners including Sequoia Capital-backed family offices and SoftBank-affiliated funds. His career includes operating roles at growth-stage companies and a spell as an entrepreneur-in-residence at Index Ventures.

Investment strategy and notable deals

Wild favors lead investments in Series A and Series B rounds, emphasizing product-market fit and unit economics demonstrated by companies such as a payments platform inspired by Stripe and a digital health startup compared with Zocdoc. He has participated in rounds alongside Andreessen Horowitz, Benchmark, Bessemer Venture Partners, and Kleiner Perkins in sectors including insurtech, biotech spinouts, and enterprise cloud computing. Notable portfolio companies tied to his deals include a challenger bank reminiscent of Monzo, a cloud infrastructure firm in the vein of HashiCorp, and an AI-driven diagnostics company with comparisons to Tempus and Flatiron Health. Wild advocates for recurring-revenue metrics popularized by investors in SaaStr circles and applies diligence techniques informed by precedents from SV Angel and First Round Capital.

Board memberships and advisor roles

Wild has served on the boards and advisory councils of several startups and nonprofit organizations. Corporate board roles have included chairing early-stage firms linked to London Stock Exchange-listed partners and advising scale-ups that later collaborated with Amazon Web Services and Google Cloud Platform. He has been an entrepreneur-in-residence and mentor at accelerator programs such as Seedcamp and Entrepreneur First, and held an advisory role with university technology transfer offices at Imperial College London and Stanford University. Institutional affiliations include trustee positions for charitable foundations aligned with Gates Foundation-style healthcare initiatives and strategic advisor roles to private equity sponsors similar to Silver Lake.

Public profile, media and philanthropy

Wild maintains a public profile through speaking engagements at events like SXSW, Mobile World Congress, and Davos satellite sessions, and has been profiled in outlets such as Financial Times, The Economist, Bloomberg, and Forbes. He contributes op-eds on venture trends and has appeared on panels with investors from Lightspeed Venture Partners and journalists from The Wall Street Journal. His philanthropic activity includes donations and pro bono advisory work for global health projects modeled on Clinton Health Access Initiative efforts and support for entrepreneurship education programs affiliated with Kauffman Foundation initiatives.

Controversies and criticisms

Wild's career has drawn criticism common to high-profile venture investors, including debates over governance practices in portfolio companies and alignment between founders and limited partners similar to disputes reported at firms like WeWork and Theranos-adjacent controversies. Some activist investors and commentators in The Guardian and New York Times-style outlets have questioned board decisions where he was present, particularly on dilution and secondary sale timing. He has also faced scrutiny over potential conflicts of interest when advising corporate venture arms while participating in private rounds, an issue discussed in investigations into industry actors such as SoftBank Vision Fund and other crossover investors.

Category:Venture capitalists Category:Alumni of the University of Cambridge Category:Harvard Business School alumni